메뉴 건너뛰기




Volumn 88, Issue 5-6, 2011, Pages 333-339

Drug interaction in psycho-oncology: Antidepressants and antineoplastics

Author keywords

Antidepressants; Antineoplastic drugs; Drug interactions

Indexed keywords

ALTRETAMINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CHLORMETHINE; CISPLATIN; CITALOPRAM; CYTOCHROME P450; DULOXETINE; ENDOXIFEN; ESCITALOPRAM; ESTRAMUSTINE; FLUOROURACIL; FLUOXETINE; FLUVOXAMINE; GEMCITABINE; IMATINIB; LOMUSTINE; MELPHALAN; MERCAPTOPURINE; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; SERTRALINE; TAMOXIFEN; TEMOZOLOMIDE; TIOGUANINE; UNINDEXED DRUG; VENLAFAXINE;

EID: 82055175104     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000334738     Document Type: Review
Times cited : (48)

References (36)
  • 1
    • 33751039773 scopus 로고    scopus 로고
    • Detection and treatment of depressive and anxiety disorders among cancer patients: Feasibility and preliminary findings from a liaison service in an oncology division
    • DOI 10.1002/da.20198
    • Pasquini M, Biondi M, Costantini A, Cairoli F, Ferrarese G, Picardi A, Sternberg C: Detection and treatment of depressive and anxiety disorders among cancer patients: Feasibility and preliminar findings from a Liason Service in an Oncology division. Depress Anxiety 2006; 23: 441-448. (Pubitemid 44757154)
    • (2006) Depression and Anxiety , vol.23 , Issue.7 , pp. 441-448
    • Pasquini, M.1    Biondi, M.2    Costantini, A.3    Cairoli, F.4    Ferrarese, G.5    Picardi, A.6    Sternberg, C.7
  • 4
    • 12344305375 scopus 로고    scopus 로고
    • Prevalence of depression in patients with cancer
    • Massie MJ: Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; 32: 57-71.
    • (2004) J Natl Cancer Inst Monogr , vol.32 , pp. 57-71
    • Massie, M.J.1
  • 5
    • 34547968264 scopus 로고    scopus 로고
    • Psychiatric concomitants of cancer, screening procedures, and training of health care professionals in oncology: The paradigms of psycho-oncology in the psychiatry field
    • in Christodoulou GN (ed) Athens, Beta Publishing Athens
    • Grassi L, Holland JC, Johansen C, Koch U, Fawzy F: Psychiatric concomitants of cancer, screening procedures, and training of health care professionals in oncology: The paradigms of psycho-oncology in the psychiatry field; in Christodoulou GN (ed): Advances in Psychiatry. Athens, Beta Publishing Athens, 2005.
    • (2005) Advances in Psychiatry
    • Grassi, L.1    Holland, J.C.2    Johansen, C.3    Koch, U.4    Fawzy, F.5
  • 7
    • 0037094076 scopus 로고    scopus 로고
    • Depression and functional status as predictors of death among cancer patients
    • DOI 10.1002/cncr.10533
    • Stommel M, Given BA, Given CW: Depression and functional status as predictors of death among cancer patients. Cancer 2002; 94: 2719-2727. (Pubitemid 34478089)
    • (2002) Cancer , vol.94 , Issue.10 , pp. 2719-2727
    • Stommel, M.1    Given, B.A.2    Given, C.W.3
  • 8
    • 39549088291 scopus 로고    scopus 로고
    • Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer
    • DOI 10.1002/pon.1213
    • Okamura M, Akizuki N, Nakano T, Shimizu K, Ito T, Akechi T, Uchitomi Y: Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. Psychooncology 2008; 17: 154-160. (Pubitemid 351279866)
    • (2008) Psycho-Oncology , vol.17 , Issue.2 , pp. 154-160
    • Okamura, M.1    Akizuki, N.2    Nakano, T.3    Shimizu, K.4    Ito, T.5    Akechi, T.6    Uchitomi, Y.7
  • 10
    • 0025015295 scopus 로고
    • Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period
    • Stiefel FC, Komblith AB, Holland JC: Changes in prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer 1990; 65: 1048-1053. (Pubitemid 20063514)
    • (1990) Cancer , vol.65 , Issue.4 , pp. 1048-1053
    • Stiefel, F.C.1    Kornblith, A.B.2    Holland, J.C.3
  • 12
    • 0031597103 scopus 로고    scopus 로고
    • Psychotropic drug metabolism in cancer patients: Clinical aspects of management of potential drug interactions
    • Kalash GR: Psychotropic drug metabolism in cancer patients: Clinical aspects of management of potential drug interactions. Psychooncology 1998; 7: 307-320.
    • (1998) Psychooncology , vol.7 , pp. 307-320
    • Kalash, G.R.1
  • 13
    • 84984535800 scopus 로고    scopus 로고
    • Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression
    • Yap KY, Ho YX, Chui WK, Chan A: Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression. Acta Oncol 2010; 49: 1235-1245.
    • (2010) Acta Oncol , vol.49 , pp. 1235-1245
    • Yap, K.Y.1    Ho, Y.X.2    Chui, W.K.3    Chan, A.4
  • 16
    • 0030867948 scopus 로고    scopus 로고
    • Pharmacokinetic drug interactions of new antidepressants: A review of the effects on the metabolism of other drugs
    • Richelson E: Pharmacokinetic drug interactions of new antidepressants: A review of the effects on metabolism of other drugs. Mayo Clin Proc 1997; 72: 835-847. (Pubitemid 27382924)
    • (1997) Mayo Clinic Proceedings , vol.72 , Issue.9 , pp. 835-847
    • Richelson, E.1
  • 17
    • 33847109783 scopus 로고    scopus 로고
    • The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: Review and recommendations for avoiding adverse drug interactions
    • DOI 10.1007/s00520-006-0127-5
    • Haddad A, Davis M, Lagman R: The pharmacological importance of cytochrome CYP3A4 in palliation of symptoms: Review and recommendations for avoiding adverse drug interactions. Support Care Cancer 2007; 15: 251-257. (Pubitemid 46295205)
    • (2007) Supportive Care in Cancer , vol.15 , Issue.3 , pp. 251-257
    • Haddad, A.1    Davis, M.2    Lagman, R.3
  • 18
    • 76649089656 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population cohort study
    • Kelly MC, Juurlink DN, Gomes T, Duon- Hua M, Pritchard KI, Austin PC, Paszat LF: Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population cohort study. BMJ 2010; 340:c693.
    • (2010) BMJ , vol.340
    • Kelly, M.C.1    Juurlink, D.N.2    Gomes, T.3    Duon- Hua, M.4    Pritchard, K.I.5    Austin, P.C.6    Paszat, L.F.7
  • 19
    • 74549144558 scopus 로고    scopus 로고
    • Interactions between tamoxifen and antidepressants via cytochrome P450 2D6
    • Desmarais JE, Looper KJ: Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. J Clin Psychiatry 2009; 70: 1688-1697.
    • (2009) J Clin Psychiatry , vol.70 , pp. 1688-1697
    • Desmarais, J.E.1    Looper, K.J.2
  • 22
    • 0037421590 scopus 로고    scopus 로고
    • Pharmacogenomics - Drug disposition, drug targets, and side effects
    • DOI 10.1056/NEJMra020526
    • Evans WE, McLeod HL: Pharmacogenomics - Drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538-549. (Pubitemid 36159890)
    • (2003) New England Journal of Medicine , vol.348 , Issue.6 , pp. 538-549
    • Evans, W.E.1    McLeod, H.L.2
  • 24
    • 70349929431 scopus 로고    scopus 로고
    • Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen
    • Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S, et al: Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA 2009; 302: 1429-1436.
    • (2009) JAMA , vol.302 , pp. 1429-1436
    • Schroth, W.1    Goetz, M.P.2    Hamann, U.3    Fasching, P.A.4    Schmidt, M.5    Winter, S.6
  • 25
    • 43649090742 scopus 로고    scopus 로고
    • Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy
    • DOI 10.1111/j.1349-7006.2008.00780.x
    • Kiyotani K, Mushiroda T, Sasa M, Bando Y, Sumitomo I, Hosono N, et al: Impact of CYP2D6 * 10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy. Cancer Sci 2008; 99: 995-999. (Pubitemid 351997603)
    • (2008) Cancer Science , vol.99 , Issue.5 , pp. 995-999
    • Kiyotani, K.1    Mushiroda, T.2    Sasa, M.3    Bando, Y.4    Sumitomo, I.5    Hosono, N.6    Kubo, M.7    Nakamura, Y.8    Zembutsu, H.9
  • 26
    • 47749105202 scopus 로고    scopus 로고
    • Association between CYP2D6 * 10 genotype and survival of breast cancer patients receiving tamoxifen treatment
    • Xun Y, Sun Y, Yao L, Shi L, Wu Y, Ouyang T, et al: Association between CYP2D6 * 10 genotype and survival of breast cancer patients receiving tamoxifen treatment. Ann Oncol 2008; 19: 1423-1429.
    • (2008) Ann Oncol , vol.19 , pp. 1423-1429
    • Xun, Y.1    Sun, Y.2    Yao, L.3    Shi, L.4    Wu, Y.5    Ouyang, T.6
  • 27
    • 19944434201 scopus 로고    scopus 로고
    • CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment
    • Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, et al: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005; 97: 30-39.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 30-39
    • Jin, Y.1    Desta, Z.2    Stearns, V.3    Ward, B.4    Ho, H.5    Lee, K.H.6
  • 29
    • 0030887069 scopus 로고    scopus 로고
    • Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes
    • DOI 10.1007/s002280050247
    • Yue QY, Säwe J: Different effects of inhibitors on the O-And N-demethylation of codeine in human liver microsomes. Eur J Clin Pharmacol 1997; 52: 41-47. (Pubitemid 27168210)
    • (1997) European Journal of Clinical Pharmacology , vol.52 , Issue.1 , pp. 41-47
    • Yue, Q.Y.1    Sawe, J.2
  • 30
    • 18544367973 scopus 로고    scopus 로고
    • Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome p450 enzymes in vitro: Mechanism of drug interaction between TCAs and phenytoin
    • Shin JG, Parks JY, Kim MJ, Shon JH, Yoo YR, Cha IJ, et al: Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome p450 enzymes in vitro: Mechanism of drug interaction between TCAs and phenytoin. Drug Metab Dispos 2002; 30: 1102-1107.
    • (2002) Drug Metab Dispos , vol.30 , pp. 1102-1107
    • Shin, J.G.1    Parks, J.Y.2    Kim, M.J.3    Shon, J.H.4    Yoo, Y.R.5    Cha, I.J.6
  • 32
    • 13444278490 scopus 로고    scopus 로고
    • Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: An in vitro study
    • DOI 10.1124/dmd.104.002428
    • Obach RS, Cox LM, Tremaine LM: Sertraline is metabolized by multiple cytochrome P450 enzymes monoamine oxidases, and glucuronyl transferases in human: An in vitro study. Drug metabolism and disposition. Drug Metab Dispos 2005; 33: 262-270. (Pubitemid 40216594)
    • (2005) Drug Metabolism and Disposition , vol.33 , Issue.2 , pp. 262-270
    • Obach, R.S.1    Cox, L.M.2    Tremaine, L.M.3
  • 33
    • 34248525832 scopus 로고    scopus 로고
    • Examination of drug-drug interaction of milnacipran hydrochloride in the presence of human P-450
    • Kazuhisa T, Kazuyuki T, Katsuya O, Satoko K, Noriaki S, Yasufumi S: Examination of drug-drug interaction of milnacipran hydrochloride in the presence of human P-450. Iyakuhin Kenkyu 2000; 31: 659-667.
    • (2000) Iyakuhin Kenkyu , vol.31 , pp. 659-667
    • Kazuhisa, T.1    Kazuyuki, T.2    Katsuya, O.3    Satoko, K.4    Noriaki, S.5    Yasufumi, S.6
  • 34
    • 24344447705 scopus 로고    scopus 로고
    • Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants
    • DOI 10.2165/00003088-200544090-00007
    • Puozzo C, Lens S, Reh C, Michaelis K, Rosillon D, Deroubais X, et al: Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants. Clin Pharmacokinet 2005; 44: 977-988. (Pubitemid 41252846)
    • (2005) Clinical Pharmacokinetics , vol.44 , Issue.9 , pp. 977-988
    • Puozzo, C.1    Lens, S.2    Reh, C.3    Michaelis, K.4    Rosillon, D.5    Deroubaix, X.6    Deprez, D.7
  • 36
    • 84855469089 scopus 로고    scopus 로고
    • Potential Interactions between Antineoplastics and Antiretrovirals ( accessed May 9 2011
    • Tony A, Tseng A: Potential Interactions between Antineoplastics and Antiretrovirals. 2011. www.hivclinic.ca/main/drugs-interact-files/Chemo-int.pdf (accessed May 9, 2011).
    • (2011)
    • Tony, A.1    Tseng, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.